EUVIMEDEUVIMED entdecken
Crossref

Personalized approach to pharmacotherapy of overactive bladder

Igor V. Kuzmin

Urology reports (St. - Petersburg) · 17.11.2023 · 13 (3) · 267-282

DOI: 10.17816/uroved569404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urology reports (St. - Petersburg), online erschienen am 17.11.2023. Verfasst von Igor V. Kuzmin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The article provides an overview of modern approaches to pharmacotherapy of overactive bladder. It has been shown that the choice of drug therapy for overactive bladder should be made taking into account the pathophysiological mechanisms of the development of the disease, the characteristics of its clinical course, as well as the potential risks of developing side effects of treatment. A pathogenetic rationale for the choice of treatment tactics for different categories of patients is presented, including those with a hypersensitive bladder, bladder outlet obstruction, neurological and geriatric patients. The pharmacological properties of the β3-adrenergic receptor agonist mirabegron are described, which provide high efficacy and a favorable safety profile in the treatment of patients with overactive bladder. The practical issues of prescribing mirabegron in various clinical situations are considered.

Zitieren

APA

Kuzmin, I. V. (2023). Personalized approach to pharmacotherapy of overactive bladder. Urology reports (St. - Petersburg), 13(3), 267-282. https://doi.org/10.17816/uroved569404

Vancouver

Kuzmin IV. Personalized approach to pharmacotherapy of overactive bladder. Urology reports (St. - Petersburg). 2023;13(3):267-282. doi:10.17816/uroved569404

BibTeX
@article{Kuzmin2023,
  author = {Kuzmin, Igor V.},
  title = {Personalized approach to pharmacotherapy of overactive bladder},
  journal = {Urology reports (St. - Petersburg)},
  year = {2023},
  volume = {13},
  number = {3},
  pages = {267--282},
  doi = {10.17816/uroved569404}
}
Kostenlos starten →